This course provides attendees with relevant information regarding new developments in gastroenterology and new approaches to the management of gastrointestinal diseases.
- Dealing with Gas and Bloating
- Non-alcoholic Fatty Liver Disease: What Is New?
Gastroenterologists, Radiologists, General Practitioners, Internal Medicine Physicians, Surgeons, Psychiatrists, Residents, Pharmacists, Pharmacy Technicians, Nurses, Nurse Practitioners, Dietitians, Physician Assistants and all other interested healthcare professionals.
- Differentiate between bloating, distension and flatulence.
- Describe the basic physiology of intestinal gas.
- List the common factors that contribute to bloating/distension and flatulence.
- Be able to recommend appropriate treatment strategies.
- Discuss the magnitude of fatty liver disease.
- Explain the natural history of fatty liver disease.
- Examine recent therapeutic strategies.
K. Rajender Reddy, M.D.
Founder's Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director, Viral Hepatitis Center
Medical Director, Liver Transplantation
University of Pennsylvania
K. Rajender Reddy, M.D., faculty for this educational activity, indicated that he received grant/research support from Mallinckrodt, Exact Sciences, Bristol Myer Squibb and Grifols. Dr. Reddy is a consultant for Pfizer, Mallinckrodt and Sparks Therapeutics. He has also indicated that he has a relationship with Novartis DSMB.
Eamonn M. M. Quigley, M.D., FRCP, FACP, MACG, FRCPI, MWGO
David M. Underwood Chair of Medicine in Digestive Disorders
Co-director, Lynda K. and David M. Underwood Center for Digestive Disorders
Chief, Gastroenterology and Hepatology
Professor of Medicine, Institute of Academic Medicine, Houston Methodist Hospital
Professor of Medicine, Weill Cornell Medical College
Adjunct Professor of Medicine, Texas A&M Health Sciences Center College of Medicine
Adjunct Professor, School of Medicine, University College Cork
Eamonn M.M. Quigley, M.D., faculty for this educational activity, indicated that he is a member of the speakers’ bureau for 4D Pharmaceuticals, Bioamerica and Vibrant. Dr. Quigley is a consultant for 4D Pharmaceuticals, Vibrant, Precisionbiotics, Novozymes, Salix and Allergan, and an adviser for Atlantia Foods.
Kenneth Rosenthal, M.D.
Co-Chair BRRH CME Committee
Boca Raton Regional Hospital
Baptist Health South Florida
Kenneth Rosenthal, M.D., conference director for this educational activity, indicated that he is a member of the speakers’ bureau for AbbVie Pharmaceuticals.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 AMA PRA Category 1 Credit™
- 1.75 General certificate of attendance
- 1.70 Florida Board of Dietitians
- 1.50 Nurse Practitioners
- 1.50 Florida Board of Nursing
- 1.75 Florida Board of Pharmacy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.